Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2004, p. 4843-4847, Vol. 48, No. 12
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.12.4843-4847.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Microbiology and Institute of Biomedical Science, College of Medicine, Hanyang University,1 Department of Internal Medicine and Liver Research Institute, College of Medicine, Seoul National University, Seoul,2 Department of Biotechnology, Joongbu University, Choongnam, South Korea3
Received 29 December 2003/ Returned for modification 21 March 2004/ Accepted 28 August 2004
Recently, the development of antibiotic resistance emerged as a significant clinical problem in the eradication of Helicobacter pylori. We investigated the MICs of antibiotics for 135 H. pylori isolates from adults in Seoul, South Korea, over the past 16 years. The MICs of amoxicillin, clarithromycin, metronidazole, tetracycline, azithromycin, and ciprofloxacin increased from 1987 to 2003. Rates of primary resistance to clarithromycin increased from 2.8% in 1994 to 13.8% in 2003. The A2144G mutation was frequently observed in the 23S rRNA gene in clarithromycin-resistant isolates. The increase in resistance to clarithromycin seems to result in a decrease in eradication efficacy for H. pylori. These results suggest that the MICs of several antibiotics for H. pylori have increased over the past 16 years in Seoul.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»